Skip to main content

Table 1 Characteristics of MetS cases (n = 92) and controls (n = 105)

From: The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study

Characteristic MetS cases (n = 92) Controls (n = 105) p
Age, years, mean ± S.D 45.33 ± 9.56 44.74 ± 9.67 0.672c
BMI, Kg/m2, mean ± S.D 37.64 ± 5.7 26.07 ± 5.4 <0.001 a
Waist (cm),mean ± S.D 119.76 ± 10.96 89.68 ± 13.87 <0.001 a
TC (mg/dl), mean ± S.D 182.12 ± 44.52 165.42 ± 22.74 0.001 a
TAG (mg/dl), mean ± S.D 177.45 ± 84.06 110.06 ± 33.25 <0.001 a
HDL-C (mg/dl), mean ± S.D 38.51 ± 9.33 44.76 ± 8.07 <0.001 a
LDL-C (mg/dl), mean ± S.D 108.11 ± 39.44 98.58 ± 20.31 0.038 a
FPG (mg/dl), median(min-max) 161(64-361) 89(60-323) <0.001 b
FSI(μIU/mL), median(min-max) 13.39(2.9–30.3) 8.5(1-30) <0.001 b
HOMA-IR, median(min-max) 4.48(0.77–20.46) 1.9(0.2-23.93) <0.001 b
QUICKI, mean ± S.D 0.31 ± 0.04 0.35 ± 0.05 <0.001 a
FTO (rs9939609)
 TT, n(%) 24 (26.1) 43 (41)  
 AT, n(%) 50 (54.4) 54 (51.4)  
 AA, n(%) 18 (19.5) 8 (7.6) 0.014 c
  1. Values are mean ± SD for parametric variables or median (range) for non-parametric variables. BMI Body mass index, WC Waist circumference, T.C Total cholesterol, TAG Triacylglycerol, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, FPG Fasting plasma glucose, FSI Fasting serum insulin
  2. aIndependent T- test, two-sided p value >0.05 non-significant
  3. bMann–Whitney U test, two sided p value >0.05 non-significant
  4. cChi-square test, two-sided p value >0.05 non-significant